Atlantic Coastal Acquisition Corp. II (ACABW) Competitors

$0.0035 0.00 (0.00%)

As of 05/1/2026

ACABW vs. AIMDW, ALVOW, RNA, BFRIW, and CELUW

Should you be buying Atlantic Coastal Acquisition Corp. II stock or one of its competitors? The main competitors of Atlantic Coastal Acquisition Corp. II include Ainos (AIMDW), Alvotech (ALVOW), Avidity Biosciences (RNA), Biofrontera (BFRIW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

How does Atlantic Coastal Acquisition Corp. II compare to Ainos?

Ainos (NASDAQ:AIMDW) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, media sentiment, risk, profitability, dividends and analyst recommendations.

: Company Net Margins Return on Equity Return on Assets
Ainos N/A N/A N/A
Atlantic Coastal Acquisition Corp. II N/A N/A N/A
: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Ainos $124.16K N/A N/A N/A N/A
Atlantic Coastal Acquisition Corp. II N/A N/A N/A N/A N/A
: In the previous week, Ainos' average media sentiment score of 0.00 equaled Atlantic Coastal Acquisition Corp. II'saverage media sentiment score.
Company Overall Sentiment
Ainos Neutral
Atlantic Coastal Acquisition Corp. II Neutral

Company	Net Margins	Return on Equity	Return on Assets
Ainos	N/A	N/A	N/A
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ainos	$124.16K	N/A	N/A	N/A	N/A
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A

Company	Overall Sentiment
Ainos	Neutral
Atlantic Coastal Acquisition Corp. II	Neutral

Summary

Ainos beats Atlantic Coastal Acquisition Corp. II on 1 of the 1 factors compared between the two stocks.

How does Atlantic Coastal Acquisition Corp. II compare to Alvotech?

Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) and Alvotech (NASDAQ:ALVOW) are both pharmaceutical products companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings, media sentiment and valuation.

: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Atlantic Coastal Acquisition Corp. II N/A N/A N/A N/A N/A
Alvotech $586.32M N/A N/A N/A N/A
: Company Net Margins Return on Equity Return on Assets
Atlantic Coastal Acquisition Corp. II N/A N/A N/A
Alvotech N/A N/A N/A
: In the previous week, Atlantic Coastal Acquisition Corp. II's average media sentiment score of 0.00 equaled Alvotech'saverage media sentiment score.
Company Overall Sentiment
Atlantic Coastal Acquisition Corp. II Neutral
Alvotech Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A
Alvotech	$586.32M	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A
Alvotech	N/A	N/A	N/A

Company	Overall Sentiment
Atlantic Coastal Acquisition Corp. II	Neutral
Alvotech	Neutral

Summary

Alvotech beats Atlantic Coastal Acquisition Corp. II on 1 of the 1 factors compared between the two stocks.

How does Atlantic Coastal Acquisition Corp. II compare to Avidity Biosciences?

Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) and Avidity Biosciences (NASDAQ:RNA) are both pharmaceutical products companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings, media sentiment and valuation.

: Atlantic Coastal Acquisition Corp. II has higher earnings, but lower revenue than Avidity Biosciences.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Atlantic Coastal Acquisition Corp. II N/A N/A N/A N/A N/A
Avidity Biosciences $18.62M N/A -$322.30M N/A N/A
: Avidity Biosciences has a consensus target price of $69.42, suggesting a potential upside of 437.31%. Given Avidity Biosciences' stronger consensus rating and higher probable upside, analysts plainly believe Avidity Biosciences is more favorable than Atlantic Coastal Acquisition Corp. II.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Atlantic Coastal Acquisition Corp. II
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
Avidity Biosciences
1 Sell rating(s)

12 Hold rating(s)

5 Buy rating(s)

1 Strong Buy rating(s)
2.32
: Atlantic Coastal Acquisition Corp. II has a net margin of 0.00% compared to Avidity Biosciences' net margin of -3,650.39%. Atlantic Coastal Acquisition Corp. II's return on equity of 0.00% beat Avidity Biosciences' return on equity.
Company Net Margins Return on Equity Return on Assets
Atlantic Coastal Acquisition Corp. II N/A N/A N/A
Avidity Biosciences -3,650.39% -44.92% -39.57%
: In the previous week, Avidity Biosciences had 1 more articles in the media than Atlantic Coastal Acquisition Corp. II. MarketBeat recorded 1 mentions for Avidity Biosciences and 0 mentions for Atlantic Coastal Acquisition Corp. II. Atlantic Coastal Acquisition Corp. II's average media sentiment score of 0.00 equaled Avidity Biosciences'average media sentiment score.
Company Overall Sentiment
Atlantic Coastal Acquisition Corp. II Neutral
Avidity Biosciences Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A
Avidity Biosciences	$18.62M	N/A	-$322.30M	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Atlantic Coastal Acquisition Corp. II	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Avidity Biosciences	1 Sell rating(s)	12 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.32

Company	Net Margins	Return on Equity	Return on Assets
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A
Avidity Biosciences	-3,650.39%	-44.92%	-39.57%

Company	Overall Sentiment
Atlantic Coastal Acquisition Corp. II	Neutral
Avidity Biosciences	Neutral

Summary

Avidity Biosciences beats Atlantic Coastal Acquisition Corp. II on 6 of the 9 factors compared between the two stocks.

How does Atlantic Coastal Acquisition Corp. II compare to Biofrontera?

Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) and Biofrontera (NASDAQ:BFRIW) are both pharmaceutical products companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings, media sentiment and valuation.

: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Atlantic Coastal Acquisition Corp. II N/A N/A N/A N/A N/A
Biofrontera $41.71M N/A N/A N/A N/A
: Company Net Margins Return on Equity Return on Assets
Atlantic Coastal Acquisition Corp. II N/A N/A N/A
Biofrontera N/A N/A N/A
: In the previous week, Biofrontera had 1 more articles in the media than Atlantic Coastal Acquisition Corp. II. MarketBeat recorded 1 mentions for Biofrontera and 0 mentions for Atlantic Coastal Acquisition Corp. II. Atlantic Coastal Acquisition Corp. II's average media sentiment score of 0.00 equaled Biofrontera'saverage media sentiment score.
Company Overall Sentiment
Atlantic Coastal Acquisition Corp. II Neutral
Biofrontera Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A
Biofrontera	$41.71M	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A
Biofrontera	N/A	N/A	N/A

Company	Overall Sentiment
Atlantic Coastal Acquisition Corp. II	Neutral
Biofrontera	Neutral

Summary

Biofrontera beats Atlantic Coastal Acquisition Corp. II on 2 of the 2 factors compared between the two stocks.

How does Atlantic Coastal Acquisition Corp. II compare to Celularity?

Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) and Celularity (NASDAQ:CELUW) are both pharmaceutical products companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, risk, earnings, media sentiment and dividends.

: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Atlantic Coastal Acquisition Corp. II N/A N/A N/A N/A N/A
Celularity $26.55M N/A N/A N/A N/A
: Company Net Margins Return on Equity Return on Assets
Atlantic Coastal Acquisition Corp. II N/A N/A N/A
Celularity N/A N/A N/A
: In the previous week, Atlantic Coastal Acquisition Corp. II's average media sentiment score of 0.00 equaled Celularity'saverage media sentiment score.
Company Overall Sentiment
Atlantic Coastal Acquisition Corp. II Neutral
Celularity Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A
Celularity	$26.55M	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A
Celularity	N/A	N/A	N/A

Company	Overall Sentiment
Atlantic Coastal Acquisition Corp. II	Neutral
Celularity	Neutral

Summary

Celularity beats Atlantic Coastal Acquisition Corp. II on 1 of the 1 factors compared between the two stocks.

Get Atlantic Coastal Acquisition Corp. II News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACABW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ACABW vs. The Competition

Export

Metric	Atlantic Coastal Acquisition Corp. II	Shell Companies Industry	Financial Sector	NASDAQ Exchange
Market Cap	N/A	$84.98M	$5.62B	$11.87B
Dividend Yield	N/A	5.35%	5.26%	5.21%
P/E Ratio	N/A	0.95	15.82	28.47
Price / Sales	N/A	286.16	979.36	60.92
Price / Cash	N/A	164.52	49.13	36.52
Price / Book	N/A	42.17	4.42	6.67
Net Income	N/A	-$131.69M	$1.15B	$332.53M
7 Day Performance	N/A	0.42%	1.00%	2.03%
1 Month Performance	N/A	0.55%	4.05%	9.23%
1 Year Performance	N/A	10.93%	21.64%	39.62%

Atlantic Coastal Acquisition Corp. II Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ACABW Atlantic Coastal Acquisition Corp. II	N/A	$0.00 flat	N/A	N/A	$0.00	N/A	N/A	15
AIMDW Ainos	N/A	$0.08 -7.1%	N/A	N/A	$0.00	$124.16K	N/A	40	Positive News
ALVOW Alvotech	N/A	$0.21 -14.2%	N/A	N/A	$0.00	$586.32M	N/A	4	Positive News Upcoming Earnings Gap Up
RNA Avidity Biosciences	1.3257 of 5 stars	$13.49 -2.6%	$69.42 +414.6%	N/A	$0.00	$18.62M	N/A	190
BFRIW Biofrontera	N/A	$0.03 -24.4%	N/A	N/A	$0.00	$41.71M	N/A	70	Positive News Upcoming Earnings Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ACABW) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Atlantic Coastal Acquisition Corp. II (ACABW) Competitors

ACABW vs. AIMDW, ALVOW, RNA, BFRIW, and CELUW

How does Atlantic Coastal Acquisition Corp. II compare to Ainos?

Summary

How does Atlantic Coastal Acquisition Corp. II compare to Alvotech?

Summary

How does Atlantic Coastal Acquisition Corp. II compare to Avidity Biosciences?

Summary

How does Atlantic Coastal Acquisition Corp. II compare to Biofrontera?

Summary

How does Atlantic Coastal Acquisition Corp. II compare to Celularity?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ACABW vs. The Competition

Atlantic Coastal Acquisition Corp. II Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Atlantic Coastal Acquisition Corp. II (ACABW) Competitors

ACABW vs. AIMDW, ALVOW, RNA, BFRIW, and CELUW

How does Atlantic Coastal Acquisition Corp. II compare to Ainos?

Summary

How does Atlantic Coastal Acquisition Corp. II compare to Alvotech?

Summary

How does Atlantic Coastal Acquisition Corp. II compare to Avidity Biosciences?

Summary

How does Atlantic Coastal Acquisition Corp. II compare to Biofrontera?

Summary

How does Atlantic Coastal Acquisition Corp. II compare to Celularity?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ACABW vs. The Competition

Atlantic Coastal Acquisition Corp. II Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools